| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |